Cancer Patient Registry Software Market: Global Industry Research Report 2020-2027 | Envisage Research

Cancer Patient Registry Software Market - By Type (Integrated Software, Standalone Software), By End User (Government Organizations & Third-party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, Research Centres) and By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 201

Status: Published

Report Code: EMR100416

The Cancer Patient Registry Software Market is expected to reach USD 2.88 million by 2027 from USD 1.2 million in 2020, at a CAGR of 10.41 % during the forecast period. Increasing incidence of cancer and a growing number of accountable care organizations are among factors driving the market growth. According to WHO, cancer accounted for around 9.6 million deaths globally and around 17 million new cases were diagnosed in 2018.

The cancer registry software helps automate data collection for national and state registries, which further helps track the effectiveness of different treatment approaches. Moreover, the data collected by the state registries help understand and address the disease in a better way. The collected data is pivotal to target risk factors such as tobacco use, sun exposure, or some environmental factors including chemical & radiation exposure. This information is also necessary for identifying locations where screening and treatment options should be tracked and improved. Moreover, registry data is useful for research institutes to estimate the efficiency of cancer control, treatment, & prevention program.

The adoption of cancer registry software is anticipated to increase shortly owing to various advantages such as efficient workflow management, ease of use, automated case registries, updates, and effective follow up. It helps in connecting remote patients, thereby widening the scope for epidemiological research.

As per NIH, cancer is a national burden and is the second leading cause of death in the U.S. Cancer costs an estimated USD 107 billion in healthcare expenditures and lost productivity from illness & death every year. Rising adoption of EHR and patient engagement solutions is further anticipated to boost the demand for cancer registry software.

Cancer registry in hospitals can help clinicians evaluate therapy results and plan treatment accordingly. Developed and developing countries are working toward implementing the software in all hospitals to track the disease and provide a framework for assessing and controlling the impact. However, data security-related issues, privacy policies, and low awareness may restrain growth shortly.
The key market players in the cancer patient registry software market are Elekta (Sweden), &(US), CNET Global Solutions &(US), Rocky Mountain Cancer Data Systems (RMCDS) (US), McKesson Corporation &US)

Analyst Commentary

The use of integrated software is increasing in the healthcare industry mainly due to the industry’s changing landscape, the need to streamline and optimize workflows and decrease physician workloads. Also, factors such as increasing government focus on population health management, coordinated care, and reducing healthcare costs are boosting the market growth.

Research centres mainly use cancer patient registry software to track patients who are eligible for clinical trials. Researchers utilize data from the registry primarily for product development. Many research agencies have built their records to maintain a database of patients suffering from various forms of cancer. Besides, some research centres support the development of cancer patient registries in coordination with healthcare centres and associations.

Segmentation

The cancer patient registry software market is segmented based on type, end user and region. On the basis of type the market is segmented into Integrated Software, Standalone Software. Based on end user the market is segmented into Government Organizations & Third-party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, Research Centres.

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global cancer registry software market owing to the rising prevalence of cancer, innovative product development and increasing investment in research and development for innovation in the region. According to the National Cancer Institute, there were 1,735,350 new cases of cancer in the US in 2018.

Europe is expected to hold the second largest position in the global cancer registry software market owing to the presence of strong academic & research base and availability of funding for research in the European countries.

The Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing government initiatives being undertaken in this region. The Ministry of Health Labour and Welfare in Japan has undertaken initiatives to improve the existing healthcare infrastructure. China has also launched its 12th Five-year Plan to upgrade Regional Healthcare Information Networks (RHINs) for rural citizens of the country. Moreover, the shift of pharmaceutical companies to low-cost manufacturing countries such as China and India is further propelling the growth of the Asia Pacific market. However, weak infrastructure, low quality, and insufficient coverage are some of the major factors, which may limit growth soon

The Middle East & Africa has the least share of the global cancer registry software market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Global Cancer Patient Registry Solutions Market
Chapter 5. Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
5.1. Global Cancer Patient Registry Solutions Market Share, By Type, 2015 - 2027 (USD Million)
5.1.1. Integrated Software
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Standalone Software
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
6.1. Global Cancer Patient Registry Solutions Share, By End-Users, 2015 - 2027 (USD Million)
6.1.1. Into Government Organizations & Third-Party Administrators
6.1.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Hospitals & Medical Practices
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.3. Pharmaceutical, Biotechnology
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.4. Others
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Cancer Patient Registry Solutions Market Overview, By Geography, 2015 – 2027 (USD Million)
7.1. Global Cancer Patient Registry Solutions Market Share, By Geography, 2015 - 2027 (USD Million)
7.1.1. Market Size and projections, by Countries, 2015 – 2027 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2019 (%)
Chapter 8. North America Global Cancer Patient Registry Solutions Market Overview, By Countries, 2015 - 2027 (USD Million)
8.1. North America Global Cancer Patient Registry Solutions Market Overview, 2015 - 2027 (USD Million)
8.1.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.2. North America Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.3. North America Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
8.1.4. North America Global Cancer Patient Registry Solutions Market Overview, By Countries, 2015 - 2027 (USD Million)
8.1.4.1. U.S. Global Cancer Patient Registry Solutions Market Overview, 2015 - 2027 (USD Million)
8.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.1.2. U.S. Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.4.1.3. U.S. Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
8.1.4.2. Canada Global Cancer Patient Registry Solutions Market Overview, 2015 - 2027 (USD Million)
8.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.2.2. Canada Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.4.2.3. Canada Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
8.1.4.3. Mexico Global Cancer Patient Registry Solutions Market Overview, 2015 - 2027 (USD Million)
8.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.3.2. Mexico Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.4.3.3. Mexico Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
Chapter 9. Europe Global Cancer Patient Registry Solutions Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1. Europe Global Cancer Patient Registry Solutions Market Overview, 2015 – 2027 (USD Million)
9.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.2. Europe Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.3. Europe Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
9.1.4. Europe Global Cancer Patient Registry Solutions Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.4.1. Germany
9.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.1.2. Germany Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.1.3. Germany Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
9.1.4.2. France
9.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.2.2. France Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.2.3. France Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
9.1.4.3. UK
9.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.3.2. UK Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.3.3. UK Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
9.1.4.4. Italy
9.1.4.4.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.4.2. Italy Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.4.3. Italy Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
9.1.4.5. Spain
9.1.4.5.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.5.2. Spain Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.5.3. Spain Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
9.1.4.6. Rest of Europe
9.1.4.6.1. Market size and projections, 2015 – 2025
9.1.4.6.2. Rest of Europe Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.6.3. Rest of Europe Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
Chapter 10. Asia Pacific Global Cancer Patient Registry Solutions Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1. Asia Pacific Cancer Patient Registry Solutions Market Overview, 2015 - 2027 (USD Million)
10.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.2. Asia Pacific Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.3. Asia Pacific Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
10.1.4. Asia Pacific Global Cancer Patient Registry Solutions Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.4.1. India
10.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.1.2. India Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.1.3. India Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
10.1.4.2. China
10.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.2.2. China Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.2.3. China Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
10.1.4.3. Japan
10.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.3.2. Japan Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.3.3. Japan Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
10.1.4.4. South Korea
10.1.4.4.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.4.2. South Korea Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.4.3. South Korea Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
10.1.4.5. Rest of Asia Pacific
10.1.4.5.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.5.2. Rest of Asia Pacific Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.5.3. Rest of Asia Pacific Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
Chapter 11. Middle East & Africa Global Cancer Patient Registry Solutions Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Middle East & Africa Global Cancer Patient Registry Solutions Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.2. Middle East & Africa Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.3. Middle East & Africa Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
11.1.4. Middle East & Africa Global Cancer Patient Registry Solutions Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.4.1. GCC
11.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.1.2. GCC Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.1.3. GCC Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
11.1.4.2. South Africa
11.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.2.2. South Africa Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.2.3. South Africa Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
11.1.4.3. Rest of Middle East & Africa
11.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.3.2. Rest of Middle East & Africa Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.3.3. Rest of Middle East & Africa Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
Chapter 12. South America Global Cancer Patient Registry Solutions Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. South America Global Cancer Patient Registry Solutions Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.2. South America Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.3. South America Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
12.1.4. South America Global Cancer Patient Registry Solutions Market Overview, By Countries, 2015- 2026 (USD Million)
12.1.4.1. Brazil
12.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.4.1.2. Brazil Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.4.1.3. Brazil Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
12.1.4.2. Argentina
12.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.4.2.2. Argentina Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.4.2.3. Argentina Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
12.1.4.3. Rest of South America
12.1.4.3.1. Market size and projections, 2015 – 2026
12.1.4.3.2. Rest of South America Global Cancer Patient Registry Solutions Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.4.3.3. Rest of South America Cancer Patient Registry Solutions Market Overview, By End-Users, 2015 - 2027 (USD Million)
Chapter 13. Competitive Landscape
13.1. Competitive environment, 2020
13.2. Strategic framework
13.2.1. Partnership/agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Type & Unflavoured development
Chapter 14. Key Player Analysis
14.1. Elekta
14.1.1. Company overview
14.1.2. Financial perTypeance
14.1.3. Type & Unflavoured Benchmarking
14.1.4. Recent initiatives
14.1.5. SWOT analysis
14.2. Onco, INC.
14.2.1. Company overview
14.2.2. Financial perTypeance
14.2.3. Type & Unflavoured Benchmarking
14.2.4. Recent initiatives
14.2.5. SWOT analysis
14.3. CNET Global Solutions
14.4. Rocky Mountain Cancer Data Systems (RMCDS)
14.5. McKesson Corporation
Chapter 15. Global Cancer Patient Registry Solutions Market Cost Analysis
15.1. Global Cancer Patient Registry Solutions Market Key Raw Types Analysis
15.1.1. Key Raw Types
15.1.2. Price Trend of Key Raw Types
15.1.3. Key Suppliers of Raw Types
15.1.4. Market Concentration Rate of Raw Types
15.2. Proportion of Wing Cost Structure
15.2.1. Raw Types
15.2.2. Labor Cost
15.2.3. Wing Expenses
15.3. Wing Process Analysis of Unsaturated Polyester Resin (UPR) for Composites
Chapter 16. Chain, Sourcing Strategy and Downstream Buyers
16.1. Global Cancer Patient Registry Solutions Market Chain Analysis
16.2. Upstream Raw Types Sourcing
16.3. Raw Types Sources of Global Cancer Patient Registry Solutions Market Major Manufacturers in 2019
16.4. Downstream Buyers
Chapter 17. Marketing Strategy Analysis, Distributors/Traders
17.1. Marketing Channel
17.1.1. Direct Marketing
17.1.2. Indirect Marketing
17.1.3. Marketing Channel Development Trend
17.2. Market Positioning
17.2.1. Pricing Strategy
17.2.2. Brand Strategy
17.2.3. Target Electrical Damage
17.3. Distributors/Traders List
Chapter 18. Market Effect Factors Analysis
18.1. Type & Into Government Organizations & Third-Party Administrators Progress/Risk
18.1.1. Substitutes Threat
18.1.2. Type & Into Government Organizations & Third-Party Administrators Progress in Related Industry
18.2. Oncology Needs/Customer Preference Change
18.3. Economic/Political Environmental Change
Chapter 19. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Cancer Patient Registry Solutions Market share, By Type, 2020 & 2027 (%)
10. Global Cancer Patient Registry Solutions Market share, By Type 2020 & 2027 (USD Million)
11. Global Cancer Patient Registry Solutions Market share, by Integrated Software, By Type, 2020 & 2027 (USD Million)
12. Global Cancer Patient Registry Solutions Market share, by Standalone Software, By Type, 2020 & 2027 (USD Million)
13. Global Cancer Patient Registry Solutions Market share, by End-Users, 2020 & 2027 (%)
14. Global Cancer Patient Registry Solutions Market share, by Into Government Organizations & Third-Party Administrators, by End-Users, 2020 & 2027 (USD Million)
15. Global Cancer Patient Registry Solutions Market share, by Hospitals & Medical Practices, by End-Users, 2020 & 2027 (USD Million)
16. Global Cancer Patient Registry Solutions Market share, by Pharmaceutical, Biotechnology, by End-Users, 2020 & 2027 (USD Million)
17. Global Cancer Patient Registry Solutions Market share, by Others, by End-Users, 2020 & 2027 (USD Million)
18. Global Cancer Patient Registry Solutions Market share, by Type, 2020 & 2027 (%)
19. Global Cancer Patient Registry Solutions Market share, by region, 2020 - 2027(%)
20. Global Cancer Patient Registry Solutions Market share, by region, 2019 - 2027(USD Million)
21. North America Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
22. North America Global Cancer Patient Registry Solutions Market share, by Countries, 2020 & 2027 (%)
23. U.S. Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
24. Canada Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
25. Europe Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
26. Europe Global Cancer Patient Registry Solutions Market share, by Countries, 2020 & 2027 (%)
27. Spain Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
28. UK Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
29. Italy Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
30. Germany Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
31. France Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
32. Rest of Europe Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
33. Asia-Pacific Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
34. Asia-Pacific Global Cancer Patient Registry Solutions Market share, by Countries, 2020 & 2027 (%)
35. China Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
36. India Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
37. Australia Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
38. Japan Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
39. Rest of Asia-Pacific Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
40. Middle East & Africa Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
41. Middle East & Africa Global Cancer Patient Registry Solutions Market share, by Countries, 2020 & 2027 (%)
42. GCC Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
43. South Africa Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
44. Rest of Middle East & Africa Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
45. South America Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
46. Brazil Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
47. Mexico Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
48. Argentina Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)
49. Rest Of South America Global Cancer Patient Registry Solutions Market, 2020 - 2027(USD Million)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Cancer Patient Registry Solutions Market, 2020-2027 (USD Million)
4. Cancer Patient Registry Solutions requirement, by country, 2020-2027, (USD Million)
5. North America Cancer Patient Registry Solutions Market, By Type, 2020-2027 (USD Million)
6. North America Cancer Patient Registry Solutions Market, by End-Users, 2020-2027 (USD Million)
7. Europe Cancer Patient Registry Solutions Market, By Type, 2020-2027 (USD Million)
8. Europe Cancer Patient Registry Solutions Market, by End-Users, 2020-2027 (USD Million)
9. Asia Pacific Cancer Patient Registry Solutions Market, by Type, 2020-2027 (USD Million)
10. Asia Pacific Cancer Patient Registry Solutions Market, by End-Users, 2020-2027 (USD Million)
11. Middle East & Africa Global Cancer Patient Registry Solutions Market, By Type, 2020-2027 (USD Million)
12. Middle East & Africa Cancer Patient Registry Solutions Market, by End-Users, 2020-2027 (USD Million)
13. South America Cancer Patient Registry Solutions Market, By Type, 2020-2027 (USD Million)
14. South America Cancer Patient Registry Solutions Market, by End-Users, 2020-2027 (USD Million)
15. Global Cancer Patient Registry Solutions Market, Company Market Share, 2018 (%)
16. Elekta : Product Benchmarking
17. Elekta : Financial PerTypeance
18. Onco, INC. : Product Benchmarking
19. Onco, INC. : Financial PerTypeance
20. CNET Global Solutions : Product Benchmarking
21. CNET Global Solutions : Financial PerTypeance
22. Rocky Mountain Cancer Data Systems (RMCDS) :Product Benchmarking
23. Rocky Mountain Cancer Data Systems (RMCDS) :Financial PerTypeance
24. McKesson Corporation : Product Benchmarking
25. McKesson Corporation : Financial PerTypeance

The Leading Key Players in Cancer Patient Registry Software Market

Elekta (Sweden)
&(US)
CNET Global Solutions &(US)
Rocky Mountain Cancer Data Systems (RMCDS) (US)
McKesson Corporation &US)